Prices as at 24 Jun 2022.
Fund commentary last updated 06 Oct 2021.
Past performance is not an indication of future performance.
Capital at risk.
|Dividends paid||30 Jun|
|Standard Initial Charge||0%|
|Initial Charge Via BestInvest||0%|
|Additional Bid/Offer Spread||0%|
|Annual Management Charge||0.75%|
|Ongoing Charges Figure||0.77%|
The fund focuses on small-cap companies because of their upside potential when it comes to profit and ultimately share price growth. The team’s bottom-up investment process looks for companies that are using innovation and sometimes disruptive technology to react quickly and nimbly to market changes such as an ageing population or environmental issues. They also search for management teams with a clear growth strategy, with much of their portfolio led by founders. In addition, they target small caps with an emerging competitive advantage, few rivals and a business model which can scale in size. The team considers around 500 stocks per year, of which between 10 and 15 make it into the portfolio after a process of peer review and debate. The portfolio consists of between 75 and 150 stocks with typical holding sizes of between 0.5% and 3% depending on risk. It has a sector bias towards information technology and healthcare.
Past performance is not a guide to future performance. View full risk warning